Kroger Health, the healthcare division of The Kroger Co. (NYSE: KR), says it will start conducting rapid antibody testing at its pharmacies next month.
The test will allow patients to find out if they have been previously infected with SARS-CoV-2, the virus that causes COVID-19.
The company says the FDA-authorized rapid antibody tests are conducted using a finger-prick blood sample
Kroger says the test is already available at its Michigan and California locations and will be available at all Kroger pharmacies and clinics by the end of November.
The test costs $25 with results typically within 15 minutes.
Kroger says the test could tell customers who believe they may have been exposed to the coronavirus but were unable to access testing at the time of infection.